COVID-19: Plasma blood treatment to be trialled, the NIHR and UKRI fund research into COVID-19 infection and immunity in children and teenagers, the RCN hits back at ‘unacceptable’ PPE guidance, and Novartis is to sponsor hydroxychloroquine trials in hospitalised COVID-19 patients.
Interested in Star’s innovative outsourcing and resourcing solutions?
Contact Operations Director, Mark Ward, on 07872 105 540 or email firstname.lastname@example.org.
On the hunt for a new role, or just curious?
Visit our candidate page, submit your CV to email@example.com.
The UK is gearing up to use the blood of coronavirus survivors to treat hospital patients ill with the disease.
The Royal College of Nursing has criticised updated guidance from Public Health England on reusing personal protective equipment during severe shortages.
The National Institute for Health Research and UK Research and Innovation (UKRI) are funding new research designed to determine rates of coronavirus infection and immunity in children and teenagers across the UK, to help further shape the response to the pandemic.
Britain may hold a minute's silence next week to pay tribute to NHS workers who have died with coronavirus.
Novartis has announced that it is to sponsor a large hydroxychloroquine clinical trial in hospitalised COVID-19 patients.
While you’re here…
…and are interested in our content, why not sign up to our newsletter?
It’s just below.